Nucleoside Antimetabolite/Analog
Nucleoside antimetabolites and analogs are compounds that mimic natural nucleosides and are incorporated into DNA during replication, leading to chain termination or the inhibition of DNA synthesis. These compounds are widely used as chemotherapeutic agents in the treatment of cancer and viral infections. By disrupting DNA synthesis, nucleoside analogs induce cell cycle arrest and apoptosis. At CymitQuimica, we provide a wide range of high-quality nucleoside antimetabolites and analogs to support your research in cancer treatment, antiviral therapy, and DNA replication.
Found 1420 products of "Nucleoside Antimetabolite/Analog"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Aza-xylo-cytidine
<p>5-Aza-xylo-cytidine, a purine analog with antitumor effects, inhibits DNA synthesis and induces apoptosis in lymphoid cancers.</p>Formula:C8H12N4O5Color and Shape:SolidMolecular weight:244.2N1-Methylxylo-guanosine
N1-Methylxylo-guanosine, a purine analog, targets lymphoid cancer via DNA synthesis inhibition and apoptosis.Formula:C11H15N5O5Color and Shape:SolidMolecular weight:297.27N4-(3,3,3-Trifluoropropanoyl)cytidine
N4-(3,3,3-Trifluoropropanoyl)cytidine, a cytidine analog, inhibits DNA methyltransferases, possibly anti-metabolic and anti-cancer.Formula:C12H14F3N3O6Color and Shape:SolidMolecular weight:353.25Rev 2'-O-MOE-5MeC(Bz)-5'-amidite
Rev 2’-O-MOE-5MeC(Bz)-5’-amidite, a purine nucleoside analog, exhibits broad antitumor activity, particularly against indolent lymphoid malignancies.Formula:C50H60N5O10PColor and Shape:SolidMolecular weight:922.016-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
6-Amino-3-(furan-2-yl)-4-methoxy-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a purine nucleoside analogue, exhibits broad antitumor activity byFormula:C15H17N5O6Color and Shape:SolidMolecular weight:363.336-Amino-4-hydrozino-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
6-Amino-4-hydrozino-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a pyrimidine nucleoside analog, boasts a broad spectrum of biochemical andFormula:C10H17N7O3Color and Shape:SolidMolecular weight:283.291-(β-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine
1-(β-D-Xylofuranosyl)-N6-(m-trifluoromethylbenzyl)adenine is an adenosine analog.Formula:C18H18F3N5O4Color and Shape:SolidMolecular weight:425.363,5'-Bis(O-t-butyldimethylsilyl)-2'-O-methyl-5-methyl cytidine
3,5’-Bis(O-t-butyldimethylsilyl)-2’-O-methyl-5-methyl cytidine, a cytidine analog, inhibits DNA methyltransferases (e.g., Zebularine), exhibiting potential antiFormula:C23H45N3O5Si2Color and Shape:SolidMolecular weight:499.79N4-Benzoyl-2'-deoxy-2'-fluoro-β-D-arabinocytidine
N4-Benzoyl-2’-deoxy-2’-fluoro-β-D-arabinocytidine, a purine nucleoside analog, exhibits widespread antitumor activity, particularly against indolent lymphoidFormula:C16H16FN3O5Color and Shape:SolidMolecular weight:349.31N1-Methyl-2'-O-(2-methoxyethyl) adenosine
N1-Methyl-2’-O-(2-methoxyethyl) adenosine, a purine nucleoside analog, exhibits broad antitumor effects, particularly against indolent lymphoid malignancies.Formula:C14H21N5O5Color and Shape:SolidMolecular weight:339.35L-Inosine
CAS:L-Inosine, an endogenous purine nucleoside from adenosine metabolism, has anti-inflammatory, antinociceptive, immunomodulatory, and neuroprotective properties.Formula:C10H12N4O5Color and Shape:SolidMolecular weight:268.23Fostroxacitabine bralpamide
CAS:Fostroxacitabine bralpamide (MIV-818) is an orally active Troxacitabine-based nucleotide prodrug. Fostroxacitabine bralpamide has anticancer effects.Formula:C22H30BrN4O8PColor and Shape:SolidMolecular weight:589.373'-Deoxy-N1-Methyl inosine
3’-Deoxy-N1-Methyl inosine, a purine nucleoside analog, exhibits broad antitumor activity against indolent lymphoid malignancies.Formula:C11H14N4O4Color and Shape:SolidMolecular weight:266.252-(P-Cyanophenyl methylidene hydrazino) adenosine
2-(P-Cyanophenyl methylidene hydrazino) adenosine: a purine analog with antitumor effects via DNA synthesis inhibition and apoptosis.Formula:C18H18N8O4Color and Shape:SolidMolecular weight:410.392'-Fluoro-2'-deoxy-arabinoadenosine 5'-triphosphate triethylamine
2’-Fluoro-2’-deoxy-arabinoadenosine 5’-triphosphate (triethylamine) is a purine nucleoside analog with significant antitumor properties, particularly effectiveFormula:C34H75FN9O12P3Color and Shape:SolidMolecular weight:913.93N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine
N3-(2S)-propyluridine is a uridine analog with potential as an antiepileptic and for antihypertensive agent research.Formula:C22H35N3O10Color and Shape:SolidMolecular weight:501.53Py-MAA-Val-Cit-PAB-DX8951
CAS:Py-MAA-Val-Cit-PAB-DX8951, a purine toxin, serves as an intermediate in the synthesis of antibody-drug conjugates [1].Formula:C57H66FN11O13SColor and Shape:SolidMolecular weight:1164.262'-O-Me-5-I-U-3'-phosphoramidite
2’-O-Me-5-I-U-3’-phosphoramidite, a purine nucleoside analog, exhibits extensive antitumor activity primarily against indolent lymphoid malignancies.Formula:C40H48IN4O9PColor and Shape:SolidMolecular weight:886.71Uridine-5-oxo-acetyl-(9-fluorenylmethyl) ester
Uridine analogue with antitumor effects; inhibits DNA synthesis, induces apoptosis in lymphoid cancers.Formula:C24H24N2O9Color and Shape:SolidMolecular weight:484.46N1-Methylsulfonyl pseudouridine
N1-Methylsulfonyl pseudouridine, a purine analog, inhibits DNA synthesis and induces apoptosis in cancer.Formula:C10H14N2O8SColor and Shape:SolidMolecular weight:322.29
